| Tag | Content |
|---|
EnhancerAtlas ID | HS191-14511 |
Organism | Homo sapiens |
Tissue/cell | Trophoblast |
Coordinate | chr16:28934960-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CCCCAGAGAA GTCTCCAGCC ACCAGCAGCT GTTAGAAAGG GAAATCGCAT GTTGGGAAGG 60
GAATTTTAGG AAGTTTACTC TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG 120
TGAGAAGGTT GGGACAAAAG TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC 180
ATAGCAGCGG GGGCAGCTCT GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG 240
AGAGTAGAAA ACAGGATCAG CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA 300
CGTGGGGCGG AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG 360
AAGGCTAGAG AGCAGAGCAT TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC 420
AGAAGTCCAG ACTAAAATGA GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA 480
GGGTTGATCA ATCATCAGTG AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG 540
CTGGGAGCTA AACTTAGCTA TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT 600
GCAAATTTTA AAAGGGCGGC CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC 660
CTGCTAACCT ATCCCATAGC TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC 720
AGTATGGGGT TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 760
|
